News | November 26, 2007

Medrad Displays "CT Contrast Injection of the Future," Highlights CT Enhancements

November 27, 2007 - Medrad Inc. displayed at RSNA 2007 “CT Contrast Injection of the Future,” an exhibit about the leading role of contrast injection in CT imaging, as well as patient safety, patient-specific protocol optimization and workflow and data integration innovations that are in development by the company.

Medrad also highlighted advancements made to its Stellant CT Injection System, featuring the DualFlow simultaneous injection and scanner-injector interface technology, as well as two new additions: CardiacFlow powered by P3TTM and XDSTM Extravasation Detector.

CardiacFlow is the first application of Medrad’s P3T, Personalized Patient Protocol Technology, which uses patient-specific parameters to optimize injection timing and contrast volume, and is specifically designed for cardiac CT imaging procedures. It is U.S. FDA 510(k) pending and patent pending.

The Medrad XDS Extravasation Detector is a patented product designed to prevent moderate to severe contrast extravasations that may seriously injure patients. Because XDS technology directly senses fluid pooling under the skin to stop an injection during a CT procedure, it reportedly minimizes false positives to maintain efficient workflow. XDS is U.S. FDA 510(k) cleared as of March 2007.

For more information: www.medrad.com

Related Content

Video Plus Brochure Helps Patients Make Lung Cancer Scan Decision

Image courtesy of the American Thoracic Society

News | Lung Cancer | April 19, 2019
A short video describing the potential benefits and risks of low-dose computed tomography (CT) screening for lung...
FDA Clears GE's Deep Learning Image Reconstruction Engine
Technology | Computed Tomography (CT) | April 19, 2019
GE Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) of its Deep Learning Image...
Videos | RSNA | April 03, 2019
ITN Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies displa
Johns Hopkins Medicine First in U.S. to Install Canon Medical's Aquilion Precision
News | Computed Tomography (CT) | March 26, 2019
March 26, 2019 — Johns Hopkins Medicine now has access to the first...
At #ACC.19, Siemens unveiled a version of its go.Top platform optimized for cardiovascular imaging. The newly packaged scanner can generate the data needed to do CT-based FFR (fractional flow reserve).

At #ACC.19, Siemens unveiled a version of its go.Top platform optimized for cardiovascular imaging. The newly packaged scanner can generate the data needed to do CT-based FFR (fractional flow reserve). Photo by Greg Freiherr

Feature | Cardiac Imaging | March 22, 2019 | By Greg Freiherr
Reflecting a trend toward the increased use of...
Researchers Use Radiomics to Predict Who Will Benefit from Chemotherapy
News | Radiomics | March 21, 2019
Using data from computed tomography (CT) images, researchers may be able to predict which lung cancer patients will...
HeartFlow Analysis Successfully Stratifies Heart Disease Patients at One Year
News | CT Angiography (CTA) | March 19, 2019
Late-breaking results confirm the HeartFlow FFRct (fractional flow reserve computed tomography) Analysis enables...
Podcast | Cardiac Imaging | March 15, 2019
Debate About Coronary Testing Highlights ACC Session
Canon Medical Introduces Entry-Level Aquilion Start CT
News | Computed Tomography (CT) | March 14, 2019
Canon Medical Systems Europe B.V. introduced the all-new Aquilion Start computed tomography (CT) system to the European...
Siemens Healthineers Debuts Cardiovascular Edition of Somatom go.Top CT
News | Computed Tomography (CT) | March 14, 2019
Siemens Healthineers will introduce the Somatom go.Top Cardiovascular Edition, a new version of its established...